Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2002 | 03-2001 | 03-2000 | 03-1999 | 03-1998 | |
| Sales | 44,530 | 103,790 | 22,230 | 66,720 | 0 |
| Cost of Goods | 15,690 | 41,200 | 8,780 | 30,350 | N/A |
| Gross Profit | 28,840 | 62,590 | 13,440 | 36,360 | 31,690 |
| Operating Expenses | 17,780 | 46,690 | 11,060 | 30,190 | 9,690 |
| Operating Income | 11,750 | 16,100 | 3,170 | 6,530 | -9,690 |
| Interest Expense | 0 | 3,850 | 950 | 2,890 | 0 |
| Other Income | 50 | 330 | -20 | 40 | 0 |
| Pre-tax Income | 11,800 | 12,580 | 2,200 | 3,680 | -9,690 |
| Income Tax | 1,870 | 2,530 | 550 | 1,350 | N/A |
| Net Income Continuous | 25,994 | 10,027 | 5,539 | 2,302 | 1,413 |
| Net Income | $9,870 | $10,020 | $1,620 | $2,300 | $1,413 |
| EPS Basic Total Ops | 1.11 | 0.47 | 0.28 | 0.12 | 0.07 |
| EPS Basic Continuous Ops | 1.11 | 0.47 | 0.27 | 0.12 | 0.07 |
| EPS Diluted Total Ops | 0.99 | 0.42 | 0.26 | 0.12 | 0.07 |
| EPS Diluted Continuous Ops | 0.99 | 0.42 | 0.26 | 0.11 | 0.07 |
| EBITDA(a) | $11,750 | $21,980 | $7,580 | $10,600 | $-6,350 |